BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3154405)

  • 1. Influence of race on renal allograft survival in the pre- and postcyclosporine era.
    Barger BO; Hudson SL; Shroyer TW; Deierhoi MH; Barber WH; Curtis JJ; Julian BA; Luke RG; Diethelm AG
    Clin Transpl; 1987; ():217-33. PubMed ID: 3154405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney transplants in black recipients. HLA matching and other factors affecting long-term graft survival.
    Koyama H; Cecka JM; Terasaki PI
    Transplantation; 1994 Apr; 57(7):1064-8. PubMed ID: 8165704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of race and ethnicity on kidney allograft outcome.
    Katznelson S; Gjertson DW; Cecka JM
    Clin Transpl; 1995; ():379-94. PubMed ID: 8794281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients.
    Kerman RH; Kimball PM; Van Buren CT; Lewis RM; Kahan BD
    Transplantation; 1991 Feb; 51(2):338-42. PubMed ID: 1825242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression.
    Gaston RS; Hudson SL; Deierhoi MH; Barber WH; Laskow DA; Julian BA; Curtis JJ; Barger BO; Shroyer TW; Diethelm AG
    Transplantation; 1992 Jan; 53(1):103-9. PubMed ID: 1733054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The UNOS Scientific Renal Transplant Registry--2000.
    Cecka JM
    Clin Transpl; 2000; ():1-18. PubMed ID: 11512303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of sex, race, and ABO groups.
    Cecka JM
    Clin Transpl; 1986; ():199-221. PubMed ID: 3154403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal retransplantation: the role of race, quadruple immunosuppression, and the flow cytometry cross-match.
    Gaston RS; Shroyer TW; Hudson SL; Deierhoi MH; Laskow DA; Barber WH; Julian BA; Curtis JJ; Barger BO; Diethelm AG
    Transplantation; 1994 Jan; 57(1):47-54. PubMed ID: 8291114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA matching.
    Hata Y; Ozawa M; Takemoto SK; Cecka JM
    Clin Transpl; 1996; ():381-96. PubMed ID: 9286584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Important risk factors of allograft survival in cadaveric renal transplantation. A study of 426 patients.
    Diethelm AG; Blackstone EH; Naftel DC; Hudson SL; Barber WH; Deierhoi MH; Barger BO; Curtis JJ; Luke RG
    Ann Surg; 1988 May; 207(5):538-48. PubMed ID: 3288138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the UNOS mandatory sharing policy on recipients of the black and white races--experience at a single renal transplant center.
    Barger B; Shroyer TW; Hudson SL; Deierhoi MH; Barber WH; Curtis JJ; Phillips MG; Julian BA; Gaston RS; Laskow DA
    Transplantation; 1992 Apr; 53(4):770-4. PubMed ID: 1566342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial differences in the survival of cadaveric renal allografts. Overriding effects of HLA matching and socioeconomic factors.
    Butkus DE; Meydrech EF; Raju SS
    N Engl J Med; 1992 Sep; 327(12):840-5. PubMed ID: 1508243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of race on renal transplant outcome.
    Dawidson IJ; Coorpender L; Fisher D; Helderman H; Hull A; Palmer B; Peters P; Sagalowsky A; Sandor ZF; Toto R
    Transplantation; 1990 Jan; 49(1):63-7. PubMed ID: 2301030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Race effects.
    Koyama H; Cecka JM
    Clin Transpl; 1991; ():269-80. PubMed ID: 1820122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DQ matching in cadaveric renal transplantation.
    Freedman BI; Thacker LR; Heise ER; Adams PL
    Clin Transplant; 1997 Oct; 11(5 Pt 2):480-4. PubMed ID: 9361945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes of renal allograft loss in black vs. white transplant recipients in the cyclosporine era.
    Valente JF; Hariharan S; Peddi VR; Schroeder TJ; Ogle CK; Alexander JW; First MR
    Clin Transplant; 1997 Jun; 11(3):231-6. PubMed ID: 9193848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of HLA A, B, and DR blood transfusions and immune responder status on cardiac allograft recipients treated with cyclosporine.
    Kerman RH; van Buren CT; Lewis RM; Frazier OH; Cooley D; Kahan BD
    Transplantation; 1988 Feb; 45(2):333-7. PubMed ID: 3278425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful transplantation of cyclosporine-treated allograft recipients with serologically positive historical, but negative preoperative, donor crossmatches.
    Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Kahan BD
    Transplantation; 1985 Dec; 40(6):615-9. PubMed ID: 3907031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of HLA frequency differences in races on the access to optimally HLA-matched cadaver renal transplants. The Medical Advisory Committee.
    Lazda VA
    Transplantation; 1992 Feb; 53(2):352-7. PubMed ID: 1738929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.